Ang (1–7), one of the significant enzymatic products of ACE2, has been shown to attenuate Ang II-induced pathological cardiac hypertrophy by its cardioprotective effects mediated by Mas receptors through different signaling pathways. This evidence concerns the gene ANGPT1 and cardiac hypertrophy.